Government ContextGovernment Context
TopicsAgenciesDocumentsPricingLog inCreate account
TopicsAgenciesDocumentsPricing
LoginCreate account
DetailsRelated

Attachment 4-Draft labeling for the proposed drug product

Supporting & Related MaterialFDA-2026-P-7602-0006
Document

Details

The document's own metadata, straight from the source system.

Title
Attachment 4-Draft labeling for the proposed drug product
Posted
Jul 8, 2026
Agency
Food and Drug Administration (FDA)
View on regulations.gov ↗
Related

Related documents

Other documents filed with this rulemaking.

View related documents
Other
Suitability Petition from Senores Pharmaceuticals, Inc
No comment periodJul 8, 2026
Other
Acknowledgment Letter from FDA DMB to Senores Pharmaceuticals, Inc
No comment periodJul 8, 2026
Supporting & Related Material
Attachment 1-Orange Book Pages
No comment periodJul 8, 2026
Supporting & Related Material
Attachment 3-Prescribing Information-GLUCOPHAGE
No comment periodJul 8, 2026
Supporting & Related Material
Attachment 2-Reference Standard approved labeling
No comment periodJul 8, 2026

On this page

DetailsRelated
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies — built on primary sources across the federal government.

ExploreDocumentsTopicsAgencies
CompanyAboutData sourcesPricing
LegalPrivacyTerms
© 2026 Government Context. Built on primary government sources.Not affiliated with any U.S. government agency.